Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies

Marie Schoumacher(Institut Curie), Mike F. Burbridge(Institut de Relations Internationales et Stratégiques)
Current Oncology Reports
March 1, 2017
Cited by 125


Related Papers